Free Trial

Generali Asset Management SPA SGR Has $11.13 Million Stock Position in Lam Research Corporation $LRCX

Lam Research logo with Computer and Technology background

Key Points

  • Generali Asset Management SPA SGR has reduced its stake in Lam Research Corporation by 29.6%, now holding 114,369 shares valued at approximately $11.13 million.
  • Wall Street analysts have a consensus rating of "Moderate Buy" for Lam Research, with a price target averaging $123.80, reflecting optimism about the company's future performance.
  • Lam Research announced a dividend increase to $0.26 per share, up from $0.23, highlighting the company's ongoing commitment to return value to shareholders.
  • Five stocks we like better than Lam Research.

Generali Asset Management SPA SGR cut its holdings in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 29.6% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 114,369 shares of the semiconductor company's stock after selling 48,135 shares during the period. Generali Asset Management SPA SGR's holdings in Lam Research were worth $11,133,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of LRCX. Smallwood Wealth Investment Management LLC acquired a new position in Lam Research in the 1st quarter valued at $26,000. REAP Financial Group LLC bought a new position in shares of Lam Research in the second quarter worth $31,000. 1 North Wealth Services LLC acquired a new position in Lam Research in the first quarter valued at about $36,000. Rossby Financial LCC bought a new stake in Lam Research during the first quarter worth about $37,000. Finally, Saudi Central Bank bought a new stake in Lam Research during the first quarter worth about $37,000. 84.61% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Weiss Ratings reissued a "buy (b-)" rating on shares of Lam Research in a research note on Wednesday, October 8th. Needham & Company LLC upped their price objective on Lam Research from $110.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, July 31st. Raymond James Financial raised their price objective on Lam Research from $90.00 to $110.00 and gave the company an "outperform" rating in a research note on Thursday, July 31st. UBS Group boosted their target price on Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research note on Monday, July 21st. Finally, Wells Fargo & Company raised their price target on shares of Lam Research from $98.00 to $135.00 and gave the company an "equal weight" rating in a research note on Thursday, October 2nd. Twenty-three research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $123.80.

Get Our Latest Analysis on Lam Research

Lam Research Stock Up 0.4%

Shares of NASDAQ LRCX opened at $138.31 on Wednesday. The company has a 50 day simple moving average of $116.42 and a 200 day simple moving average of $95.48. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55. Lam Research Corporation has a 1 year low of $56.32 and a 1 year high of $153.70. The firm has a market cap of $174.41 billion, a PE ratio of 33.25, a price-to-earnings-growth ratio of 1.67 and a beta of 1.84.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. Lam Research's revenue for the quarter was up 33.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.03 earnings per share. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, research analysts forecast that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be paid a $0.26 dividend. This is an increase from Lam Research's previous quarterly dividend of $0.23. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 24th. Lam Research's payout ratio is presently 25.00%.

Insider Buying and Selling

In other news, SVP Vahid Vahedi sold 52,190 shares of the company's stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president directly owned 251,047 shares of the company's stock, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.31% of the stock is owned by insiders.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

See Also

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Lam Research Right Now?

Before you consider Lam Research, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.

While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Undervalued Energy Stocks Under $20 with Big Potential
3 Stocks, 3 Stories — and 3 Big Reasons to Buy
Big Market Shifts You Can’t Ignore: Where Investors Are Moving Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines